Relay Therapeutics (RLAY) Preferred Stock Liabilities (2020)
Historic Preferred Stock Liabilities for Relay Therapeutics (RLAY) over the last 1 years, with Q2 2020 value amounting to $537.8 million.
Historic Preferred Stock Liabilities for Relay Therapeutics (RLAY) over the last 1 years, with Q2 2020 value amounting to $537.8 million.
| Date | Value |
|---|---|
Offer Ends In
Starting from $49 $19 / month